For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Aldeyra Therapeutics, Inc.

USPTO Granted Patents = 39

CIPO Patents = 1

EPO Patents = 2

Trademarks = 3

Forward Citations = 570

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Todd Brady (17 out of 17 patents)

Scott Young (15 out of 15 patents)

William Alvin Kinney (15 out of 65 patents)

4. Stephen Gitu Machatha (12 out of 12 patents)

5. Thomas A Jordan (11 out of 14 patents)

6. John Clifford Chabala (11 out of 29 patents)

7. Susan Macdonald (10 out of 10 patents)

8. Kenneth Jason Mandell (8 out of 20 patents)

9. John E Dowling (7 out of 10 patents)

10. David J Clark (3 out of 72 patents)

11. Hannah Ruth McLachlan (3 out of 3 patents)

12. Gregor Sneddon (3 out of 3 patents)

13. Dean Eliott (3 out of 9 patents)

14. Jonathan James Loughrey (3 out of 13 patents)

15. Tomasz Stryjewski (3 out of 3 patents)

39 patents: Sort by Forward Citations

1. 12240816 - Deuterated compounds and uses thereof (2025-03-04),

2. 12128013 - Toxic aldehyde related diseases and treatment (2024-10-29),

3. 12098132 - Process for preparation of aldehyde scavenger and intermediates (2024-09-24),

4. 12097188 - Compositions and methods for the treatment of macular degeneration (2024-09-24),

5. 12064516 - Pharmaceutical formulations and uses thereof (2024-08-20),

6. 12029735 - Polymorphic compounds and uses thereof (2024-07-09),

7. 12006298 - Polymorphic compounds and uses thereof (2024-06-11),

8. 12005061 - Ophthalmic formulations of methotrexate (2024-06-11),

9. 12005060 - Ophthalmic formulations of methotrexate (2024-06-11),

10. 11911385 - Methotrexate treatment methods (2024-02-27),

11. 11845722 - Deuterated compounds and uses thereof (2023-12-19),

12. 11786518 - Ophthalmic formulations and uses thereof (2023-10-17),

13. 11771664 - Toxic aldehyde related diseases and treatment (2023-10-03),

14. 11724987 - Compositions and methods of treating retinal disease (2023-08-15),

15. 11701331 - Toxic aldehyde related diseases and treatment (2023-07-18),

Aldeyra Therapeutics, Inc. is a biotechnology company focused on the development of innovative therapies for various ocular and systemic diseases. With a strong emphasis on ocular inflammation and immune modulation, Aldeyra is dedicated to the discovery and commercialization of novel pharmacologic agents. By leveraging its proprietary technology platforms, the company aims to address unmet medical needs and improve patient outcomes in ophthalmology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#27 in Lexington, MA

#497 in Massachusetts

#8,539 in US

#16,943 in the World

Lexington, MA, United States of America

Aldeyra Therapeutics, Inc.

Forward Citations = 570

28 inventors:

Todd Brady (17 out of 17 patents)

Scott Young (15 out of 15 patents)

William Alvin Kinney (15 out of 65 patents)

4. Stephen Gitu Machatha (12 out of 12 patents)

5. Thomas A Jordan (11 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…